Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $36.52-$83.49 |
Market Cap | $3.7B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $37.3M |
Revenue Growth (YoY) | -82.3% |
Gross Profit (12 Mos) | -$393.5M |
Diluted EPS | -$4.34 |
News
See moreYahoo Finance • 16 days ago
Street Calls of the Week
Yahoo Finance • 20 days ago
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 4 months ago
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yahoo Finance • 5 months ago
3 Dirt Cheap Stocks to Buy Right Now
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |
